In addition, immunoglobulin-like transcript 2 (also known as LILRB1) can also inhibit the proliferation and cytotoxic activity of infiltrating NK cells in GC tumor tissues (208), so blocking this receptor can enhance the activation and proliferation of NK cells. The gene discussed is LILRB1; the disease is gastric cancer.